Page last updated: 2024-10-23

azathioprine and Cystadenocarcinoma, Papillary

azathioprine has been researched along with Cystadenocarcinoma, Papillary in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Cystadenocarcinoma, Papillary: An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teneriello, M1
Farley, J1
Parker, M1
O'Connor, D1
Shaver, T1
Park, R1
Barnhill, D1

Other Studies

1 other study available for azathioprine and Cystadenocarcinoma, Papillary

ArticleYear
Management of advanced ovarian epithelial cancer in the renal transplant patient.
    Gynecologic oncology, 1993, Volume: 50, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Carboplatin; Chemotherapy, Adju

1993